Company Scilex Holding Company

Equities

SCLX

US80880W1062

Pharmaceuticals

Market Closed - Nasdaq 16:00:00 2024-07-16 EDT 5-day change 1st Jan Change
1.96 USD +3.70% Intraday chart for Scilex Holding Company +8.89% -3.92%

Business Summary

Scilex Holding Company is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system) 1.8%, is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It also focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. Its second commercial product ELYXYB, is a potential first-line treatment, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults. Its product candidates include SP-102 (SEMDEXA), SP-103 and SP-104. SP-102 is a viscous gel formulation of a used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica. Its SP-103 is a triple-strength formulation of ZTlido, for the treatment of chronic neck pain.

Number of employees: 106

Sales per Business

USD in Million2022Weight2023Weight Delta
Non-Opioid Pain Management Products
100.0 %
38 100.0 % 47 100.0 % +22.90%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
38 100.0 % 47 100.0 % +22.90%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 241,258,520 118,413,727 ( 49.08 %) 60,068,585 ( 24.90 %) 43.81 %
Stock B 0 29,057,097 0 0

Shareholders

NameEquities%Valuation
SCLX Stock Acquisition JV LLC
33.15 %
60,068,585 33.15 % 116 M $
7,415,336 4.093 % 14 M $
BlackRock Advisors LLC
3.487 %
6,318,498 3.487 % 12 M $
Vanguard Global Advisers LLC
2.201 %
3,988,265 2.201 % 8 M $
1,917,210 1.058 % 4 M $
Millennium Management LLC
0.5887 %
1,066,659 0.5887 % 2 M $
Geode Capital Management LLC
0.5786 %
1,048,409 0.5786 % 2 M $
Goldman Sachs & Co. LLC
0.4886 %
885,300 0.4886 % 2 M $
Henry Ji
0.3654 %
661,996 0.3654 % 1 M $
Northern Trust Global Investments Ltd.
0.3487 %
631,848 0.3487 % 1 M $
NameEquities%Valuation
SCLX Stock Acquisition JV LLC
100.00 %
29,057,097 100.00 % 56 M $
NameEquities%Valuation
Oasis Management Co. Ltd.
0.7589 %
100,000 0.7589 % 45 000 $
Cruiser Capital Advisors LLC
0.3795 %
49,999 0.3795 % 22 500 $
Landscape Capital Management LLC
0.3326 %
43,824 0.3326 % 19 721 $
HRT Financial LLC
0.0980 %
12,917 0.0980 % 5 813 $
Clear Street LLC
0.0188 %
2,480 0.0188 % 1 116 $
Tower Research Capital LLC
0.003172 %
418 0.003172 % 188 $
UBS Securities LLC
0.000896 %
118 0.000896 % 53 $

Company contact information

Scilex Holding Co.

960 San Antonio Road

94303, Palo Alto

+

http://www.scilexholding.com
address Scilex Holding Company(SCLX)
  1. Stock Market
  2. Equities
  3. SCLX Stock
  4. Company Scilex Holding Company